Replies to post #4775 on MediPharm Labs Corp (MEDIF)

[hiroller12x]

IMO sloooow bleed back to double digits for a spell...(C-19 is just ramping up)

[DS CPA]

This is trading at:

1. Less than 2x annual sales
2. Less than 10x annual adjusted EBITDA

That is based on 2019 numbers, not forward. That is insanely cheap. This was also profitable both from GAAP and adjusted EBITDA perspectives in its first full year of Cannabis operations.

With CV at large you discount every stock, I get that. But this is not a company that is shut down, consumers are still buying cannabis products, and the numbers speak loudly here even if no one cares to listen at the moment (other investors).

That is all while ignoring the fact that this company doesn’t make widgets, it makes Cannabis products and while the sector woes have clouded some investors’ long-term aspirations, I think we can all agree this sector is still in its early stages and there is massive growth potential for the companies that become successful.